Assessment of Drug–Drug Interactions in Humans
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: closed (30 November 2021) | Viewed by 6079
Special Issue Editors
2. Université d’Angers, 40 rue de Rennes, F-49035 Angers, France
Interests: pharmacovigilance; acute and chronic kidney diseases; experimental and clinical vascular remodeling
Interests: pharmacology and pharmacokinetic–pharmacodynamic modelling; bioanalysis applied to human medicine such as therapeutic drug monitoring and clinical research methodologies; preclinical and clinical cardiovascular models
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Drug interactions are a public health concern and are at the origin of numerous adverse drug reactions. Drug interactions are a significant source of variability in drug responses. Overlooking this variability in drug response leads to decreased benefits and increased drug risks. The evaluation of drug–drug interactions in drug development and post-marketing surveillance is essential for preventing potential clinical risks for patients.
Advancements in experimental and computational techniques, and pharmacoepidemiology may improve the evaluation of drug–drug interactions and their clinical relevance. Additionally, a synthesis of the literature in the form of a review and meta-analysis is needed. New studies establishing predictive models of pharmacokinetic/pharmacodynamic interactions or their clinical impacts, integrating one or more drugs in various pathophysiological situations, are welcome. These studies’ data will serve as an individualization and anticipation tool for planning and improving patient management.
This Special Issue will highlight the current knowledge on the methods facilitating drug–drug interaction evaluations, new drug–drug interactions with significant clinical impacts, and drug–drug interactions in particular populations.
Prof. Dr. Marie Briet
Dr. Zoubir Djerada
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- population pharmacokinetics and pharmacodynamics
- drug–drug interaction
- predictive model
- meta-analysis
- pharmacoepidemiology
- drug adverse reaction
